Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP278666.RAancNA93nokAJMIKX_YWMlSev1qX0ME7AG-K_rgkE8zY130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278666.RAancNA93nokAJMIKX_YWMlSev1qX0ME7AG-K_rgkE8zY130_provenance.
• NP552261.RAbKdIXIdp_0Ib4cJnWmItFaXsj_lgcuEHvuFODBgCPeU130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552261.RAbKdIXIdp_0Ib4cJnWmItFaXsj_lgcuEHvuFODBgCPeU130_provenance.
• NP968357.RAQJ0A9-ZOcKQ4EkTrAHkDeCTHUKXfgkrTlgxlbz5QruI130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968357.RAQJ0A9-ZOcKQ4EkTrAHkDeCTHUKXfgkrTlgxlbz5QruI130_provenance.
• NP968367.RAVZv_mTVPcQQGi1ah1ZHJE_QauwW6cqMznGG3Z4EwJkA130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968367.RAVZv_mTVPcQQGi1ah1ZHJE_QauwW6cqMznGG3Z4EwJkA130_provenance.
• NP968437.RAcBKS3HJQyBz9F-laz_4RUYAzUdn1ni01EAIxnCP4wdc130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968437.RAcBKS3HJQyBz9F-laz_4RUYAzUdn1ni01EAIxnCP4wdc130_provenance.
• NP1011245.RAVZWmP3mgLUfwcEdIs1mHCfN7283OJbk4bxevIQn4koc130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011245.RAVZWmP3mgLUfwcEdIs1mHCfN7283OJbk4bxevIQn4koc130_provenance.
• assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP277833.RADla6iYfkta1gJWXu5iZchciezfIw_7Y9wSwf9-Pw0EI130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277833.RADla6iYfkta1gJWXu5iZchciezfIw_7Y9wSwf9-Pw0EI130_provenance.
• NP499636.RAawZPg1eGcSlrjk4mKCO6PKxcRBhQJCv937cRl7F_ef0130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499636.RAawZPg1eGcSlrjk4mKCO6PKxcRBhQJCv937cRl7F_ef0130_provenance.
• NP499648.RAWygl6qM4OrhpJYZcXFW5TyPr1AhDuLvNvmLcbum0VZc130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499648.RAWygl6qM4OrhpJYZcXFW5TyPr1AhDuLvNvmLcbum0VZc130_provenance.
• NP499649.RAf4njKtvvJ0Wd56fLaj193-3-ncTxIUF8BkDf7-i4GQw130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499649.RAf4njKtvvJ0Wd56fLaj193-3-ncTxIUF8BkDf7-i4GQw130_provenance.
• NP499650.RAYTnxN2k23QqTLK28-CX6MdRD9qgjB2rZCnk1QGPenys130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499650.RAYTnxN2k23QqTLK28-CX6MdRD9qgjB2rZCnk1QGPenys130_provenance.
• NP499652.RAZKs4u1utPlyK4yoJk4MNrI1nJs5UWw299qsOdul7_mE130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499652.RAZKs4u1utPlyK4yoJk4MNrI1nJs5UWw299qsOdul7_mE130_provenance.
• NP499653.RASjiVKz2uE6ad252O49r4rsu8FZBO2zbK-c-bbOo7KsI130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499653.RASjiVKz2uE6ad252O49r4rsu8FZBO2zbK-c-bbOo7KsI130_provenance.
• NP352986.RArda7JAgGNjprVpWx7Rbneh0H_Mc47wcUBkJOjc4ZAbA130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352986.RArda7JAgGNjprVpWx7Rbneh0H_Mc47wcUBkJOjc4ZAbA130_provenance.
• NP1011175.RAh6hI7oIJ0IBrtx54hKopdKH0gbfkzQU2TKr46ga4aX8130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011175.RAh6hI7oIJ0IBrtx54hKopdKH0gbfkzQU2TKr46ga4aX8130_provenance.
• NP499635.RAiWIdCCaUkjA-yX4XFtxhkgF_k_X5d9j7hcpjxnInjds130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499635.RAiWIdCCaUkjA-yX4XFtxhkgF_k_X5d9j7hcpjxnInjds130_provenance.
• NP499638.RAi4xoppUNsh5d__povHkas9daZSbBNPkx2cbr0PWNQYQ130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499638.RAi4xoppUNsh5d__povHkas9daZSbBNPkx2cbr0PWNQYQ130_provenance.
• NP499642.RAhlGxOgRgZfZFKBPeuovkeUESsrSU1kYsX-iL0vIM5zI130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499642.RAhlGxOgRgZfZFKBPeuovkeUESsrSU1kYsX-iL0vIM5zI130_provenance.
• NP499643.RAkYJiDJVvq_egcojj-vSudg_wzctXofAXI9ne5KyLWaM130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499643.RAkYJiDJVvq_egcojj-vSudg_wzctXofAXI9ne5KyLWaM130_provenance.
• NP499644.RAkuhcbm2QPV4ZzSegZ3FEMzZXNhjddvSh_03_e7guUzE130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499644.RAkuhcbm2QPV4ZzSegZ3FEMzZXNhjddvSh_03_e7guUzE130_provenance.
• NP499646.RAnfieMQDZ1dXaQtstQQHtR36jQLuQXeqfCYaKYvFM6d4130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499646.RAnfieMQDZ1dXaQtstQQHtR36jQLuQXeqfCYaKYvFM6d4130_provenance.
• NP499651.RApn3npMCqrhZySf_U6FUAQ1Xp5dF734eN8fczKlt06Y8130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499651.RApn3npMCqrhZySf_U6FUAQ1Xp5dF734eN8fczKlt06Y8130_provenance.
• NP278554.RA_GMComIwU5LThUnzBt6BpmU_o4P2F-KJjAXMEuPe_UY130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278554.RA_GMComIwU5LThUnzBt6BpmU_o4P2F-KJjAXMEuPe_UY130_provenance.
• NP278564.RA6KklobbYcmWMnjtAEVOEi5NvVDqjF8Sz0yMyTIZawDw130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278564.RA6KklobbYcmWMnjtAEVOEi5NvVDqjF8Sz0yMyTIZawDw130_provenance.
• NP352922.RAzVdLJUZqmqEhKsHSRJZp_HcOMBQHLwFnGgYRvKu4MaQ130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352922.RAzVdLJUZqmqEhKsHSRJZp_HcOMBQHLwFnGgYRvKu4MaQ130_provenance.
• NP552251.RAFanExz2zZUV3bJx-CIKSWYt87f7QJy062poga61o7o8130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552251.RAFanExz2zZUV3bJx-CIKSWYt87f7QJy062poga61o7o8130_provenance.
• NP352912.RAPJqLnJvPqX1XreKLew_tjQoGLQTft88zmHSrzlx_xHg130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352912.RAPJqLnJvPqX1XreKLew_tjQoGLQTft88zmHSrzlx_xHg130_provenance.
• NP552315.RAx7BijSfEB25dNZqyuYDqL9luV1dtn1I01azRO6QHlDM130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552315.RAx7BijSfEB25dNZqyuYDqL9luV1dtn1I01azRO6QHlDM130_provenance.
• NP277754.RAJJ66_eEmYnSqGHFOnIhoxjFLqQGJOBL29K9pe2pCGYg130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277754.RAJJ66_eEmYnSqGHFOnIhoxjFLqQGJOBL29K9pe2pCGYg130_provenance.
• NP277765.RAJMAnNfU6wpPugnuyX7TdmiMQ-_6WsttY9Rcrw4Ixkcs130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277765.RAJMAnNfU6wpPugnuyX7TdmiMQ-_6WsttY9Rcrw4Ixkcs130_provenance.
• NP1011185.RA3gDXn1-b9EICbW3aAtA-fCvwTXEkqikJN-yd-UxX_d8130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011185.RA3gDXn1-b9EICbW3aAtA-fCvwTXEkqikJN-yd-UxX_d8130_provenance.
• NP499637.RA94o6zNO_cKMzXY1-AZMirzws4cPL7CXIbVJW4Zxdw3c130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499637.RA94o6zNO_cKMzXY1-AZMirzws4cPL7CXIbVJW4Zxdw3c130_provenance.
• NP499639.RA8w4bAzWHncAkNK2QMSbmIRmt87E3U7ydyo26EzLioKk130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499639.RA8w4bAzWHncAkNK2QMSbmIRmt87E3U7ydyo26EzLioKk130_provenance.
• NP499640.RA2QQs6OM89O2zxVIVKrYxKT0EBs2GNQ-_JszG-0JYyGs130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499640.RA2QQs6OM89O2zxVIVKrYxKT0EBs2GNQ-_JszG-0JYyGs130_provenance.
• NP499641.RA_Ma9cLxUUsDID4SZUNp73nxuDgl9xJAi9nv3kKz6SCs130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499641.RA_Ma9cLxUUsDID4SZUNp73nxuDgl9xJAi9nv3kKz6SCs130_provenance.
• NP499647.RA26y39MG8h2fJluwVxO869IpNKJkKqJeIRRLXn9_4w6w130_assertion description "[A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499647.RA26y39MG8h2fJluwVxO869IpNKJkKqJeIRRLXn9_4w6w130_provenance.